Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new revision entry: v3.3.4, and removed the previous revision entry: v3.3.3 from the Record History version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedFooter shows Revision: v3.3.3 and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These are site maintenance metadata changes and do not alter trial data.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Record History now lists a new revision tag (v3.3.2) and removes v3.3.1, which is a metadata update to the history log rather than a change to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedVersion history shows a new revision (v3.3.1) with sponsor naming updated to BeOne Medicines (BeiGene) and status/identification updates. The previous sponsor entry BeiGene and the earlier revision v3.2.0 are listed as deletions.SummaryDifference0.7%

- Check67 days agoChange DetectedRemoved a banner notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check82 days agoChange DetectedVersion 11 was posted on 2025-04-11, updating the record with changes to the study status and IPD sharing information for NCT04379635.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.